ELEKTA TO SUPPLY CHU DE POITIERS HOSPITAL CENTER IN FRANCE WITH ADVANCED TECHNOLOGY FOR IMAGE GUIDED RADIATION THERAPY

CHU (University Hospital Center) de Poitiers has selected Elekta as the main partner in an ambitious program to improve radiation therapy treatment capacity in the Poitou-Charente region. Replacing equipment from a different vendor, the hospital recently assigned Elekta to deliver three Elekta Synergy® digital linear accelerator systems for intensity modulated and image guided radiation therapy. The order is valued at close to EUR 5 M.

Stockholm Sweden — Sunday, January 20, 2008

Intensity modulated and image guided radiation therapy (IMRT & IGRT) has during the last couple of years become standard for new deliveries of radiation therapy solutions and Elekta Synergy is being established as the reference system for this more precise and accurate method for radiating cancer tumors.

CHU de Poitiers, the only Radiotherapy Center focusing on advanced radiation therapy in the Poitiers area has chosen to upgrade their facilities and replace older equipment from another vendor with three Elekta Synergy systems.

“Radiation therapy is one of the most important weapons in the arsenal to fight cancer”, comments Mr Jean-Pierre Dewitte, CEO of Poitiers University Hospital. “Integrated 3D imaging, which is what is needed for true image guided treatment, will most certainly be one key factor for future improved outcomes. We surveyed the market thoroughly and found Elekta to have the most clinically proven and workflow-centric solution on the market”, ends Mr Dewitte.

Elekta Synergy enables the radiation oncology staff to use extremely precise and accurate technique close to critical structures, while at the same time being flexible enough to handle virtually all cases presented in a radiation therapy department.

“We are very pleased to partner with CHU de Poitiers in the effort to improve cancer care and we are looking forward to working with Mr Dewitte and the radiation therapy department at CHU Poitiers to explore advanced methods such as in-Vivo dosimetry, gating and VMAT (Volumetric Intensity Modulated Radiation Therapy)”, comments Vincent Beilvert, Managing Director of Elekta France.

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.lee@elekta.com
Time zone: EDT: Eastern Daylight Time